Changes to regulations on opioid supply in Australia came into effect this week, with new Pharmaceutical Benefits Scheme listings resulting in smaller quantities and restrictions around opioid prescribing for pain treatment.

The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.

Pharmacists should act as patient champions when it comes to accessing emergency contraception – and that means getting rid of the checklist.

The changes to ongoing Continued Dispensing arrangements after the expiry of the emergency measure came as a shock to many pharmacists.

All pharmacists can soon dispense MS-2 Step, following a landmark decision by the Therapeutic Goods Administration.

As regulatory bodies restrict or ban carisoprodol, the highly addictive but effective muscle relaxant still dominates the US prescription drug market. Carisoprodol, marketed in the...